Clinical Trial Update: Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

View source ↗

Summary

This clinical trial update notes the PROTECT Extension study evaluating long-term safety of teplizumab in recent-onset type 1 diabetes; the study status is acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Teplizumab (Teplizumab)

Snippet

Sponsor: Provention Bio, a Sanofi Company | Conditions: Diabetes Mellitus, Type 1 | Status: ACTIVE_NOT_RECRUITING